Company / Depreciation & Amortization
KYNTRA BIO, INC. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.7M
FY2025
5-year range
$2.7M / $11.7M
FY2021-FY2025
Trend
-72.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has declined for 3 consecutive years, from $12M in FY2022 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -16.6%.
Improved from $10M to $3M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -39.0%
- 5-Year CAGR
- -16.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- KYNTRA BIO, INC.'s depreciation & amortization has declined for 3 consecutive years.
- 5-year CAGR of -16.6%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 72.1% year-over-year.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7M | -72.1% |
| FY2024 | $9.5M | -6.4% |
| FY2023 | $10.2M | -12.9% |
| FY2022 | $11.7M | +4.8% |
| FY2021 | $11.1M | +69.9% |
| FY2020 | $6.6M | +7.6% |
| FY2019 | $6.1M | +1.0% |
| FY2018 | $6.0M | +6.4% |
| FY2017 | $5.7M | +27.0% |
| FY2016 | $4.5M | -12.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026